AAAAAA

   
Results: 1-25 | 26-48
Results: 1-25/48
FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE
Authors: LIU SY EARY JF PETERSDORF SH MARTIN PJ MALONEY DG APPELBAUM FR MATTHEWS DC BUSH SA DURACK LD FISHER DR GOOLEY TA BERNSTEIN ID PRESS OW
Citation: Sy. Liu et al., FOLLOW-UP OF RELAPSED B-CELL LYMPHOMA PATIENTS TREATED WITH IODINE-131-LABELED ANTI-CD20 ANTIBODY AND AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 16(10), 1998, pp. 3270-3278
THE NOTCH LIGAND, JAGGED-1, INFLUENCES THE DEVELOPMENT OF PRIMITIVE HEMATOPOIETIC PRECURSOR CELLS
Authors: VARNUMFINNEY B PURTON LE YU M BRASHEMSTEIN C FLOWERS D STAATS S MOORE KA LEROUX I MANN R GRAY G ARTAVANISTSAKONAS S BERNSTEIN ID
Citation: B. Varnumfinney et al., THE NOTCH LIGAND, JAGGED-1, INFLUENCES THE DEVELOPMENT OF PRIMITIVE HEMATOPOIETIC PRECURSOR CELLS, Blood, 91(11), 1998, pp. 4084-4091
IMPORTANCE OF PRETREATMENT RADIATION ABSORBED DOSE ESTIMATION FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA
Authors: EARY JF KROHN KA PRESS OW DURACK L BERNSTEIN ID
Citation: Jf. Eary et al., IMPORTANCE OF PRETREATMENT RADIATION ABSORBED DOSE ESTIMATION FOR RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Nuclear medicine and biology, 24(7), 1997, pp. 635-638
TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) WITH RECOMBINANT ENGINEERED HUMAN ANTI-CD33 ANTIBODY-CALICHEAMICIN DRUG CONJUGATE
Authors: SIEVERS EL BERNSTEIN ID SPIELBERGER RT FORMAN SJ SHANNONDORCY K APPELBAUM FR
Citation: El. Sievers et al., TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) WITH RECOMBINANT ENGINEERED HUMAN ANTI-CD33 ANTIBODY-CALICHEAMICIN DRUG CONJUGATE, European journal of cancer, 33, 1997, pp. 398-398
NORMAL IMMUNOLOGICAL RESPONSE TO A NEOANTIGEN, BACTERIOPHAGE-PHI-X-174, IN BABOONS WITH LONG-TERM LYMPHOHEMATOPOIETIC RECONSTITUTION FROM HIGHLY PURIFIED CD34(-) ALLOGENEIC MARROW-CELLS() LIN()
Authors: ANDREWS RG WINKLER A POTTER J BRYANT E KNITTER GH BERNSTEIN ID OCHS HD
Citation: Rg. Andrews et al., NORMAL IMMUNOLOGICAL RESPONSE TO A NEOANTIGEN, BACTERIOPHAGE-PHI-X-174, IN BABOONS WITH LONG-TERM LYMPHOHEMATOPOIETIC RECONSTITUTION FROM HIGHLY PURIFIED CD34(-) ALLOGENEIC MARROW-CELLS() LIN(), Blood, 90(4), 1997, pp. 1701-1708
ALL-TRANS-RETINOIC ACID INDUCES ENHANCED CFC GENERATION IN CULTURES OF HIGHLY ENRICHED MURINE HEMATOPOIETIC STEM-CELLS
Authors: PURTON LE COLLINS SJ ANDREWS RG BERNSTEIN ID
Citation: Le. Purton et al., ALL-TRANS-RETINOIC ACID INDUCES ENHANCED CFC GENERATION IN CULTURES OF HIGHLY ENRICHED MURINE HEMATOPOIETIC STEM-CELLS, Blood, 90(10), 1997, pp. 3391-3391
INFREQUENT CLONAL LOSS OF HETEROZYGOSITY (LOH) IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA
Authors: CHEN CS GALIPEAU PC BARRETT MT FLOWERS DA REID BJ BERNSTEIN ID
Citation: Cs. Chen et al., INFREQUENT CLONAL LOSS OF HETEROZYGOSITY (LOH) IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA, Blood, 90(10), 1997, pp. 280-280
PHASE-I STUDY OF I-131 ANTI-CD45 ANTIBODY PLUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR ADVANCED ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Authors: MATTHEWS DC APPELBAUM FR EARY JF MITCHELL D PRESS OW BERNSTEIN ID
Citation: Dc. Matthews et al., PHASE-I STUDY OF I-131 ANTI-CD45 ANTIBODY PLUS CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION FOR ADVANCED ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Blood, 90(10), 1997, pp. 1854-1854
SELECTIVE ABLATION OF ACUTE MYELOID-LEUKEMIA USING AN ANTI-CD33 CALICHEAMICIN IMMUNOCONJUGATE
Authors: SIEVERS EL APPELBAUM FA SPIELBERGER RT FORMAN SJ FLOWERS DA BERGER MS SHANNONDORCY K BERNSTEIN ID
Citation: El. Sievers et al., SELECTIVE ABLATION OF ACUTE MYELOID-LEUKEMIA USING AN ANTI-CD33 CALICHEAMICIN IMMUNOCONJUGATE, Blood, 90(10), 1997, pp. 2246-2246
MARROW ABLATIVE AND IMMUNOSUPPRESSIVE EFFECTS OF I-131 ANTI-CD45 ANTIBODY IN CONGENIC AND H-2 MISMATCHED MURINE TRANSPLANT MODELS
Authors: MATTHEWS DC MARTIN PJ NOURIGAT C APPELBAUM FR BERNSTEIN ID
Citation: Dc. Matthews et al., MARROW ABLATIVE AND IMMUNOSUPPRESSIVE EFFECTS OF I-131 ANTI-CD45 ANTIBODY IN CONGENIC AND H-2 MISMATCHED MURINE TRANSPLANT MODELS, Blood, 90(10), 1997, pp. 2509-2509
MLL GENE REARRANGEMENT, CYTOGENETIC 11Q23 ABNORMALITIES, AND EXPRESSION OF THE NG2 MOLECULE IN INFANT ACUTE MYELOID-LEUKEMIA
Authors: HILDEN JM SMITH FO FRESTEDT JL MCGLENNEN R HOWELLS WB SORENSEN PHB ARTHUR DC WOODS WG BUCKLEY J BERNSTEIN ID KERSEY JH
Citation: Jm. Hilden et al., MLL GENE REARRANGEMENT, CYTOGENETIC 11Q23 ABNORMALITIES, AND EXPRESSION OF THE NG2 MOLECULE IN INFANT ACUTE MYELOID-LEUKEMIA, Blood, 89(10), 1997, pp. 3801-3805
PREDICTION OF RELAPSE OF PEDIATRIC ACUTE MYELOID-LEUKEMIA BY USE OF MULTIDIMENSIONAL FLOW-CYTOMETRY
Authors: SIEVERS EL LANGE BJ BUCKLEY JD SMITH FO WELLS DA DAIGNEAULTCREECH CA SHULTS KE BERNSTEIN ID LOKEN MR
Citation: El. Sievers et al., PREDICTION OF RELAPSE OF PEDIATRIC ACUTE MYELOID-LEUKEMIA BY USE OF MULTIDIMENSIONAL FLOW-CYTOMETRY, Journal of the National Cancer Institute, 88(20), 1996, pp. 1483-1488
EFFECTS OF FLT3 LIGAND ON ACUTE MYELOID AND LYMPHOCYTIC LEUKEMIC BLAST CELLS FROM CHILDREN
Authors: MCKENNA HJ SMITH FO BRASEL K HIRSCHSTEIN D BERNSTEIN ID WILLIAMS DE LYMAN SD
Citation: Hj. Mckenna et al., EFFECTS OF FLT3 LIGAND ON ACUTE MYELOID AND LYMPHOCYTIC LEUKEMIC BLAST CELLS FROM CHILDREN, Experimental hematology, 24(2), 1996, pp. 378-385
RADIOIMMUNOTHERAPY TREATMENT PLANNING BASED ON RADIATION ABSORBED DOSE OR PATIENT SIZE
Authors: EARY JF KROHN KA PRESS OW FISHER D BERNSTEIN ID
Citation: Jf. Eary et al., RADIOIMMUNOTHERAPY TREATMENT PLANNING BASED ON RADIATION ABSORBED DOSE OR PATIENT SIZE, The Journal of nuclear medicine, 37(5), 1996, pp. 162-162
I-131 ANTI-CD45 ANTIBODY AS A PART OF A CONDITIONING REGIMEN PRIOR TOBONE-MARROW TRANSPLANTATION ACUTE-LEUKEMIA
Authors: EARY JF MATTHEWS DC APPELBAUM FR MITCHELL DA BERNSTEIN ID
Citation: Jf. Eary et al., I-131 ANTI-CD45 ANTIBODY AS A PART OF A CONDITIONING REGIMEN PRIOR TOBONE-MARROW TRANSPLANTATION ACUTE-LEUKEMIA, The Journal of nuclear medicine, 37(5), 1996, pp. 1052-1052
INHIBITION OF GRANULOCYTIC DIFFERENTIATION BY MNOTCH1
Authors: MILNER LA BIGAS A KOPAN R BRASHEMSTEIN C BERNSTEIN ID MARTIN DIK
Citation: La. Milner et al., INHIBITION OF GRANULOCYTIC DIFFERENTIATION BY MNOTCH1, Proceedings of the National Academy of Sciences of the United Statesof America, 93(23), 1996, pp. 13014-13019
COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS
Authors: PRESS OW SHAN D HOWELLCLARK J EARY J APPELBAUM FR MATTHEWS D KING DJ HAINES AMR HAMANN P HINMAN L SHOCHAT D BERNSTEIN ID
Citation: Ow. Press et al., COMPARATIVE METABOLISM AND RETENTION OF I-125, Y-90, AND IN-111 RADIOIMMUNOCONJUGATES BY CANCER-CELLS, Cancer research, 56(9), 1996, pp. 2123-2129
REGULATION OF COLONY-FORMING CELL GENERATION BY FLT-3 LIGAND
Authors: BRASHEMSTEIN C FLOWERS DA BERNSTEIN ID
Citation: C. Brashemstein et al., REGULATION OF COLONY-FORMING CELL GENERATION BY FLT-3 LIGAND, British Journal of Haematology, 94(1), 1996, pp. 17-22
I-131 ANTI-CD45 ANTIBODY PLUS BUSULFAN CYCLOPHOSPHAMIDE IN MATCHED RELATED TRANSPLANTS FOR AML IN FIRST REMISSION/
Authors: MATTHEWS DC APPELBAUM FR EARY JF MITCHELL D PRESS OW BERNSTEIN ID
Citation: Dc. Matthews et al., I-131 ANTI-CD45 ANTIBODY PLUS BUSULFAN CYCLOPHOSPHAMIDE IN MATCHED RELATED TRANSPLANTS FOR AML IN FIRST REMISSION/, Blood, 88(10), 1996, pp. 556-556
THE HUMAN HOMOLOG OF RAT NG2, A CHONDROITIN SULFATE PROTEOGLYCAN, IS NOT EXPRESSED ON THE CELL-SURFACE OF NORMAL HEMATOPOIETIC-CELLS BUT ISEXPRESSED BY ACUTE MYELOID-LEUKEMIA BLASTS FROM POOR-PROGNOSIS PATIENTS WITH ABNORMALITIES OF CHROMOSOME BAND 11Q23
Authors: SMITH FO RAUCH C WILLIAMS DE MARCH CJ ARTHUR D HILDEN J LAMPKIN BC BUCKLEY JD BUCKLEY CV WOODS WG DINNDORF PA SORENSEN P KERSEY J HAMMOND D BERNSTEIN ID
Citation: Fo. Smith et al., THE HUMAN HOMOLOG OF RAT NG2, A CHONDROITIN SULFATE PROTEOGLYCAN, IS NOT EXPRESSED ON THE CELL-SURFACE OF NORMAL HEMATOPOIETIC-CELLS BUT ISEXPRESSED BY ACUTE MYELOID-LEUKEMIA BLASTS FROM POOR-PROGNOSIS PATIENTS WITH ABNORMALITIES OF CHROMOSOME BAND 11Q23, Blood, 87(3), 1996, pp. 1123-1133
HUMAN HOMOLOG OF THE RAT CHONDROITIN SULFATE PROTEOGLYCAN, NG2, DETECTED BY MONOCLONAL-ANTIBODY 7.1, IDENTIFIES CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH T(4-11)(Q21-Q23) OR T(11-19)(Q23-P13) AND MLL GENE REARRANGEMENTS
Authors: BEHM FG SMITH FO RAIMONDI SC PUI CH BERNSTEIN ID
Citation: Fg. Behm et al., HUMAN HOMOLOG OF THE RAT CHONDROITIN SULFATE PROTEOGLYCAN, NG2, DETECTED BY MONOCLONAL-ANTIBODY 7.1, IDENTIFIES CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIAS WITH T(4-11)(Q21-Q23) OR T(11-19)(Q23-P13) AND MLL GENE REARRANGEMENTS, Blood, 87(3), 1996, pp. 1134-1139
CELLULAR BIOLOGY OF ACUTE MYELOGENOUS LEUKEMIA
Authors: SMITH FO RASKIND WH FIALKOW PJ BERNSTEIN ID
Citation: Fo. Smith et al., CELLULAR BIOLOGY OF ACUTE MYELOGENOUS LEUKEMIA, Journal of pediatric hematology/oncology, 17(2), 1995, pp. 113-122
CELL-SURFACE EXPRESSION OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN (P-170) AS DETECTED BY MONOCLONAL-ANTIBODY MRK-16 IN PEDIATRIC ACUTE MYELOID-LEUKEMIA FAILS TO DEFINE A POOR PROGNOSTIC GROUP - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: SIEVERS EL SMITH FO WOODS WG LEES JW BLEYER WA WILLMAN CL BERNSTEIN ID
Citation: El. Sievers et al., CELL-SURFACE EXPRESSION OF THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN (P-170) AS DETECTED BY MONOCLONAL-ANTIBODY MRK-16 IN PEDIATRIC ACUTE MYELOID-LEUKEMIA FAILS TO DEFINE A POOR PROGNOSTIC GROUP - A REPORT FROM THE CHILDRENS CANCER GROUP, Leukemia, 9(12), 1995, pp. 2042-2048
PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS
Authors: PRESS OW EARY JF APPELBAUM FR MARTIN PJ NELP WB GLENN S FISHER DR PORTER B MATTHEWS DC GOOLEY T BERNSTEIN ID
Citation: Ow. Press et al., PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS, Lancet, 346(8971), 1995, pp. 336-340
PRIMITIVE HUMAN HEMATOPOIETIC PRECURSORS EXPRESS BCL-X BUT NOT BCL-2
Authors: PARK JR BERNSTEIN ID HOCKENBERY DM
Citation: Jr. Park et al., PRIMITIVE HUMAN HEMATOPOIETIC PRECURSORS EXPRESS BCL-X BUT NOT BCL-2, Blood, 86(3), 1995, pp. 868-876
Risultati: 1-25 | 26-48